Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II HIV-1 DNA prime and recombinant vaccinia boost vaccine trial
CTR20190300Phase 2Active
- Sponsor
- CNAIDS
- Start
- Feb 2019
- Modality
- Viral Vector Vaccines → Recombinant Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of recombinant Tiantan vaccinia HIV vaccine in human immunodeficiency virus infection (HIV), sponsored by CNAIDS. Started Feb 2019; status: active.
02
Drugs
recombinant Tiantan vaccinia HIV vaccine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on CTR20190300.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20190300.